Cargando…
Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
[Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906590/ https://www.ncbi.nlm.nih.gov/pubmed/33644551 http://dx.doi.org/10.1021/acsomega.0c05741 |
_version_ | 1783655321698304000 |
---|---|
author | Wang, Yiyun Xu, Haojie Wang, Hongyi Zheng, Zhonghui Meng, Zihui Xu, Zhibin Li, Jiarong Xue, Min |
author_facet | Wang, Yiyun Xu, Haojie Wang, Hongyi Zheng, Zhonghui Meng, Zihui Xu, Zhibin Li, Jiarong Xue, Min |
author_sort | Wang, Yiyun |
collection | PubMed |
description | [Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2 series) were designed and synthesized, and their biological activity in inhibiting cAMP was evaluated. The IC(50) values of compounds II-1-3, II-2-1, II-2-2, II-2-3, II-2-4, and II-2-6 were 7.71, 6.52, 6.16, 7.23, 7.96, and 9.68 μg/mL, respectively, which had the same order of activity as that of istradefylline (IC(50) value was 1.94 μg/mL). The preliminary structure–activity relationship suggested that the 6-amino in adenine played an important role in binding an A(2A) receptor. The results of photostability experiments showed that the photostability of the target compounds of II-1 and II-2 series was improved when compared with that of istradefylline. |
format | Online Article Text |
id | pubmed-7906590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-79065902021-02-26 Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists Wang, Yiyun Xu, Haojie Wang, Hongyi Zheng, Zhonghui Meng, Zihui Xu, Zhibin Li, Jiarong Xue, Min ACS Omega [Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2 series) were designed and synthesized, and their biological activity in inhibiting cAMP was evaluated. The IC(50) values of compounds II-1-3, II-2-1, II-2-2, II-2-3, II-2-4, and II-2-6 were 7.71, 6.52, 6.16, 7.23, 7.96, and 9.68 μg/mL, respectively, which had the same order of activity as that of istradefylline (IC(50) value was 1.94 μg/mL). The preliminary structure–activity relationship suggested that the 6-amino in adenine played an important role in binding an A(2A) receptor. The results of photostability experiments showed that the photostability of the target compounds of II-1 and II-2 series was improved when compared with that of istradefylline. American Chemical Society 2021-02-04 /pmc/articles/PMC7906590/ /pubmed/33644551 http://dx.doi.org/10.1021/acsomega.0c05741 Text en © 2021 The Authors. Published by American Chemical Society This is an open access article published under an ACS AuthorChoice License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Wang, Yiyun Xu, Haojie Wang, Hongyi Zheng, Zhonghui Meng, Zihui Xu, Zhibin Li, Jiarong Xue, Min Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists |
title | Design, Synthesis, and Biological Activity Studies
of Istradefylline Derivatives Based on Adenine as A(2A) Receptor
Antagonists |
title_full | Design, Synthesis, and Biological Activity Studies
of Istradefylline Derivatives Based on Adenine as A(2A) Receptor
Antagonists |
title_fullStr | Design, Synthesis, and Biological Activity Studies
of Istradefylline Derivatives Based on Adenine as A(2A) Receptor
Antagonists |
title_full_unstemmed | Design, Synthesis, and Biological Activity Studies
of Istradefylline Derivatives Based on Adenine as A(2A) Receptor
Antagonists |
title_short | Design, Synthesis, and Biological Activity Studies
of Istradefylline Derivatives Based on Adenine as A(2A) Receptor
Antagonists |
title_sort | design, synthesis, and biological activity studies
of istradefylline derivatives based on adenine as a(2a) receptor
antagonists |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906590/ https://www.ncbi.nlm.nih.gov/pubmed/33644551 http://dx.doi.org/10.1021/acsomega.0c05741 |
work_keys_str_mv | AT wangyiyun designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT xuhaojie designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT wanghongyi designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT zhengzhonghui designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT mengzihui designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT xuzhibin designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT lijiarong designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists AT xuemin designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists |